drug

nacresertib

1 story · latest Nov 6, 2026

Follow nacresertib. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 2 registered trials in coverage

Relationships

Developed by AbbVie

Timeline

AbbVie posts updates on three early-stage trials: obesity, drug interaction, glabellar lines

Nov 6Weekly roundup, 5 itemsABBV-295 AbbVieUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.